Vis enkel innførsel

dc.contributor.authorHaugland, Gyri Teien
dc.contributor.authorKverme, Karen obrestad
dc.contributor.authorHannisdal, Rita
dc.contributor.authorKallekleiv, Marielle
dc.contributor.authorColquhoun, Duncan John
dc.contributor.authorLunestad, Bjørn Tore
dc.contributor.authorWergeland, Heidrun Inger
dc.contributor.authorSamuelsen, Ole Bent
dc.PublishedHaugland GT, Kverme Ko, Hannisdal R, Kallekleiv M, Colquhoun DJ, Lunestad BT, Wergeland HI, Samuelsen OB. Pharmacokinetic Data Show That Oxolinic Acid and Flumequine Are Absorbed and Excreted Rapidly From Plasma and Tissues of Lumpfish. Frontiers in Veterinary Science. 2019:6:394eng
dc.description.abstractThis study examined the uptake, tissue distribution and elimination of the antibacterial agents oxolinic acid and flumequine in lumpfish (Cyclopterus lumpus L.) by use of LC-MS/MS following a single oral administration of 25 mg/kg fish given in feed. Lumpfish are increasingly used as cleaner fish for removal of sea lice on commercially farmed salmon. The production of lumpfish is successful, but there are challenges with bacterial infections and the number of antibacterial treatments has increased in recent years. As the lumpfish is a novel species to farming, there is a need for pharmacokinetic data and establishment of protocols for efficient antibacterial treatment. The current study describes the pharmacokinetic properties of oxolinic acid and flumequine in lumpfish. Absorption of oxolinic acid was moderate and was characterized by a calculated peak plasma concentration (Cmax) of 2.12 μg/ml after 10.3 h (Tmax) and an elimination half-life (t1/2β) of 21 h. Area under curve (AUC) and AUC from 0 to 24 h (AUC0−24h) were calculated to be 60.9 and 34.0 h μg/ml, respectively. For flumequine, plasma Cmax was found to be 2.77 μg/ml after 7.7 h (Tmax) with t1/2β of 22 h. The area under the curve (AUC) and AUC from 0 to 24 h (AUC0−24) were calculated as 104.3 and 50.3 h μg/ml, respectively. Corresponding Cmax values in muscle, liver, and head-kidney for oxolinic acid were 4.01, 3.04, and, 4.68 μg/g, respectively and Tmax of 11.1, 9.2, and 10.0 h, respectively. For flumequine, Cmax values of 4.16, 4.01, and 7.48 μg/g were obtained in muscle, liver, and head kidney, respectively, with corresponding Tmax values of 10.2, 10.3, and 6.0 h. Antimicrobial susceptibility values as determined by minimum inhibitory concentration (MIC) analyses against 28 isolates of Aeromonas salmonicida isolated from diseased lumpfish ranged from 0.06 to 15 μg/ml for oxolinic acid and 0.024 to 6.25 μg/ml for flumequine. Bimodal distributions in susceptibility to both oxolinic acid and flumequine were observed. The combination of pharmacokinetic properties and MIC data make possible calculation of efficient treatment doses, which are needed to improve the welfare of lumpfish and minimize development of antibiotic resistant bacteria.en_US
dc.rightsAttribution CC BYeng
dc.titlePharmacokinetic Data Show That Oxolinic Acid and Flumequine Are Absorbed and Excreted Rapidly From Plasma and Tissues of Lumpfishen_US
dc.typePeer reviewed
dc.typeJournal article
dc.rights.holderCopyright 2019 Haugland, Kverme, Hannisdal, Kallekleiv, Colquhoun, Lunestad, Wergeland and Samuelsen.en_US
dc.source.journalFrontiers in Veterinary Science
dc.relation.projectFiskeri- og havbruksnæringens forskningsfinansiering: 901468
dc.relation.projectNorges forskningsråd: 244148

Tilhørende fil(er)


Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution CC BY
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution CC BY